Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

Home
Investire
Azioni
Germania
TG
DBS Group Holdings Ltd (DEVL)
DBS Group Holdings Ltd (DEVL) Notizie

DBS Group Holdings Ltd (DEVL)

44,855

0,255

(0,57%)

Chiuso 02 Luglio 10:00PM

Il tuo punto di riferimento per quotazioni in tempo reale, idee e discussioni live.

Premium

0 articoli trovati

bigstocksnbonds

bigstocksnbonds 5 minuti fa

LTR

LTR 6 minuti fa

I think there will be a lot selling between where we stand today and roughly the 5 dollar share price, when approval hits. A lot of us have been in this stock for multiple years and are far in the red. Many of us are approaching retirement or are already in retirement. Many of us, myself included

dewophile

dewophile 9 minuti fa

They are also heavily reliant on Dupixent and the COM patent expires in early 2031 so not that far off
Dupixent may also lose share to long acting injectables and orals targeting that pathway

overbore

overbore 11 minuti fa

I'll never compain when the share price increases but I'm surprised we didn't see more of a bump. I own shares through TSX and can confrim they did not change. Maybe tomorrow will be another trend upwards. Added more shares today. With this latest EA approval this is a bargain buy right now!

chazzy1

chazzy1 13 minuti fa

This text is a standard initial rule in a patent lawsuit. It means the person or company suing (the plaintiff) must formally list the exact products violating their patents, explain how they calculate their financial demands, and share the official government records of how their patent was approved

yadotn

yadotn 19 minuti fa

MRNJ>>>-99.92%

MRNJ
INVESTORShub
-99.92%
https://investorshub.advfn.com/stock-market/USOTC/metatron-id-MRNJ/historical

yadotn

yadotn 19 minuti fa

MRNJ>>>-99.92%

MRNJ
INVESTORShub
-99.92%

chuck1418

chuck1418 19 minuti fa

hold steady. longs gonna win here imo

searay2701

searay2701 20 minuti fa

It is now July 1, 2026, this stock’s price situation has not improved but done just the opposite, gone way down from the year it was at $1.50, and down approximately 50% from it’s last low high of $.42, now that is not a sign of a company in it’s best shape ever. This is not, or will it ever be in

gutek

gutek 29 minuti fa

https://www.sec.gov/submit-tip-or-complaint

northam43

northam43 29 minuti fa

#1.2 SPX Cycles Expanded Report: Current Cycles Between Cycles (CCBC) is -33 (Extreme Bearish). Extreme Overdue: 60 min (60-2), Daily (D-2), Weekly (W-SC-1).

https://investorshub.advfn.com/uimage/uploads/2026/7/1/jwcnf1_Status_Report.PNG

northam43

northam43 30 minuti fa

#1.2 SPX Cycles Expanded Report: Current Cycles Between Cycles (CCBC) is -33 (Extreme Bearish). Extreme Overdue: 60 min (60-2), Daily (D-2), Weekly (W-SC-1).

https://investorshub.advfn.com/uimage/uploads/2026/7/1/jwcnf1_Status_Report.PNG

Eagle1

Eagle1 32 minuti fa

Anything under the ATH is a great buy IMO.

Anyone else agree like and share.

TRAPPER JIM

TRAPPER JIM 33 minuti fa

Last time I mowed was June 7th. So it’s been a minute

Peeteman

Peeteman 35 minuti fa

Evidently when you put everything in caps it makes you more right.

midastouch017

midastouch017 37 minuti fa

The life-changing mental health treatment most Americans don’t know exists

https://www.usatoday.com/story/sponsor-story/acumen-usa250/2026/07/01/the-life-changing-mental-health-treatment-most-americans-dont-know-exists/90681643007/

July 1, 2026, 6:01 a.m. ET

FOFreddie

FOFreddie 38 minuti fa

Hi Neo, - I dont think I missed the point - we both are making a LOT of assumptions and you most important assumption is that common shareholders will not suffer dilution of any type - warrants - SPS - JPS Conversion. You get a valuation of $ 221 a share for FNMA and an implied valuation of FMCC o

3331

3331 38 minuti fa

BIEL UPDATE - HUGE - PROFITABLE
BioElectronics Issues Chairman's Update Highlighting Sales Growth, and Strategic Progress

JEFFERSON, MD - June 30, 2026 (NEWMEDIAWIRE) - BioElectronics Corporation (https://www.bielcorp.com/) (OTC: BIEL), a developer of medical technology product

3331

3331 39 minuti fa

BIEL UPDATE - HUGE - PROFITABLE
BioElectronics Issues Chairman's Update Highlighting Sales Growth, and Strategic Progress

JEFFERSON, MD - June 30, 2026 (NEWMEDIAWIRE) - BioElectronics Corporation (https://www.bielcorp.com/) (OTC: BIEL), a developer of medical technology product

bigsur25

bigsur25 41 minuti fa

Trump what are you talking about . He’s got nothing to with Opendoor.

northam43

northam43 42 minuti fa

Report #9 SPX Cycles 12 Month Range Forecast: July 2027 projections, current high & low for this month
The projected high range is based on the current year 60 min cycle average.
The projected low range is based on the 60 min cycle averages from 2011 to present

https://i

notshakenorstirred

notshakenorstirred 42 minuti fa

https://x.com/TechForce_X/status/2064922811408560324/video/1

northam43

northam43 43 minuti fa

Report #9 SPX Cycles 12 Month Range Forecast: July 2027 projections, current high & low for this month
The projected high range is based on the current year 60 min cycle average.
The projected low range is based on the 60 min cycle averages from 2011 to present

https://i

Green Leaf Smoker

Green Leaf Smoker 43 minuti fa

Well I'll be damned MJNA goes down! Here's the BEAR link to this POS ....Enough Said
https://investorshub.advfn.com/stock-market/USOTC/medical-marijuana-id-MJNA/trades#google_vignette
.....current Bail Out SP O.OOO1 No Kid wants ones 50% + stock loss 🤣😂🤣

Newbury Street Acquisition

Future Metals Nl

Bny Mellon Dynamic Value...

Cullen Resources

Imperial Mining

Nutritional Growth Solut...

URB Investments

FEC Resources (PK)

Caseys General Stores

Delayed Upgrade Clock

Assistenza: support@advfn.it

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN

Hai già un account? Accedi

Non hai un account? Registrati

Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.